Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 1/20 | 0.43 |
| ▸ | IL6ST | P40189 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.38 |
| ▸ | IDH1 | O75874 | 7/20 | 0.38 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.37 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.36 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3782695 | 1.00 | PPARA (0.43) | PPARAIL6STFAAHNAAAIDH1 | |
| SCHEMBL6671341 | 1.00 | PPARA (0.43) | PPARAIL6STFAAHNAAAIDH1 | |
| SCHEMBL13316581 | 0.90 | PPARA (0.42) | PPARAIL6STFAAHNAAAIDH1 | |
| SCHEMBL12062824 | 0.88 | PPARA (0.48) | PPARAIL6STFAAHNAAAIDH1 | |
| SCHEMBL13316601 | 0.86 | PPARA (0.41) | PPARAIL6STFAAHNAAAIDH1 | |
| SCHEMBL4610764 | 0.85 | PPARA (0.46) | PPARAIL6STFAAHNAAAIDH1 | |
| SCHEMBL22686526 | 0.85 | PPARA (0.48) | PPARAIL6STFAAHNAAAIDH1 | |
| SCHEMBL4610762 | 0.85 | PPARA (0.46) | PPARAIL6STFAAHNAAAIDH1 | |
| SCHEMBL22686527 | 0.85 | PPARA (0.48) | PPARAIL6STFAAHNAAAIDH1 | |
| SCHEMBL22686525 | 0.85 | PPARA (0.48) | PPARAIL6STFAAHNAAAIDH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8084485-B2 | 6-(aminoalkyl)indazoles | VITAE PHARMACEUTICALS, INC. (US) | 2011-12-27 | — | — | US | disclosed |
| US-20100331287-A1 | 6-(Aminoalkyl)Indazoles | VITAE PHARMACEUTICALS, INC. | 2010-12-30 | — | — | US | disclosed |
| WO-2007120523-A2 | 6-(AMINOALKYL)INDAZOLES | VITAE PHARMACEUTICALS, INC. (US) | 2007-10-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100331287-A1 | 6-(Aminoalkyl)Indazoles | REN, AGTR1, AGTR2 | PPARA 1275/4885IL6ST 912/4885FAAH 1519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.